The IGF‐1 pathway has been linked to cancer and IBD by modulating the immune system as well as through its multi‐functional involvement in the tumor microenvironment (Smith et al, 2011; Sanchez‐Lopez et al, 2016). Here, IGF1 is linked to neoplasm.